Lung cells that are susceptible to coronavirus infection decoded

PTI Berlin | Updated on April 08, 2020 Published on April 08, 2020

Scientists have discovered those cells of the lungs and bronchi that are targets for novel coronavirus infection, findings that may aid in the development of novel drug candidates to treat COVID-19.

The study, published in The EMBO Journal, revealed that the receptor for the virus is abundantly expressed in the progenitor cells of the respiratory tract which have hair-like projections to sweep mucus and bacteria out of the lungs.

Researchers, including those from the Berlin Institute of Health (BIH) in Germany, analysed samples of twelve lung cancer patients obtained from the Heidelberg Lung Biobank in Germany.

They also studied cells from the airways of healthy patients, which had been collected in a minimally invasive manner during a bronchoscopy examination performed to rule out lung cancer.

“I was convinced that the data we gathered from these non-coronavirus infected patients would provide important information for understanding the viral infection,” said study co-author Roland Eils from BIH.

“We wanted to find out which specific cells the coronavirus attacks,” explained Christian Conrad, who also works at the BIH.

The scientists said the virus’ spike protein attaches to an ACE2 receptor on the cell surface.

In addition, they said the virus needs one or more co-factors for it to be able to penetrate cells.

Using single-cell sequencing technology, the researchers sequenced the genome of 60,000 cells.

“We then analysed a total of nearly 60,000 cells to determine whether they activated the gene for the receptor and potential co-factors, thus in principle allowing them to be infected by the coronavirus,” said Soeren Lukassen, one of the lead authors of the study.

“We only found the gene transcripts for ACE2 and for the cofactor TMPRSS2 in very few cells, and only in very small numbers,” Lukassen said.

The scientists discovered that certain progenitor cells in the bronchi are mainly responsible for producing the coronavirus receptors.

These progenitor cells, they said, normally develop into respiratory tract cells lined with hair-like projections called cilia that sweep mucus and bacteria out of the lungs.

“Armed with the knowledge of which cells are attacked, we can now develop targeted therapies,” explained co-author Michael Kreuter from the Thorax Clinic at Heidelberg University Hospital in Germany.

According to the study, the ACE2 receptor density on the cells increased with age, and was generally higher in men than in women.

“This was only a trend, but it could explain why SARS-CoV-2 has infected more men than women,” Eils said.

However, the scientists said the sample sizes are too small to make conclusive statements, adding that the study needs to be repeated in larger patient cohorts.

“These results show us that the virus acts in a highly selective manner, and that it is dependent on certain human cells in order to spread and replicate,” Eils explained.

“The better we understand the interaction between the virus and its host, the better we will be able to develop effective counterstrategies,” he added.

Published on April 08, 2020

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.